Multidrug-resistant tuberculosis in children: A practical update on epidemiology, diagnosis, treatment and prevention
Open Access
- 1 May 2024
- journal article
- research article
- Published by Elsevier in Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
- Vol. 36, 100449
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant TuberculosisClinical Infectious Diseases, 2017
- Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant TuberculosisEBioMedicine, 2015
- Pharmacokinetics and Safety of Moxifloxacin in Children With Multidrug-Resistant TuberculosisClinical Infectious Diseases, 2014
- Delamanid: A new armor in combating drug-resistant tuberculosisJournal of Pharmacology and Pharmacotherapeutics, 2014
- Bedaquiline: a review of human pharmacokinetics and drug-drug interactionsJournal of Antimicrobial Chemotherapy, 2014
- Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimatesThe Lancet, 2014
- Yield of Contact Investigations in Households of Patients With Drug-Resistant Tuberculosis: Systematic Review and Meta-AnalysisClinical Infectious Diseases, 2013
- Tuberculosis in Children Exposed at Home to Multidrug-resistant TuberculosisThe Pediatric Infectious Disease Journal, 2013
- Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug ResistanceAntimicrobial Agents and Chemotherapy, 2012
- Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6Journal of Antimicrobial Chemotherapy, 2004